nach oben

Diabetologia

Erschienen in:

01.12.2007 | Letter

Comment on: Gale EAM (2007) To boldly go—or to go too boldly? The accelerator hypothesis revisited. Diabetologia 50:1571–1575—a reply to the editor

verfasst von: T. J. Wilkin

Erschienen in: Diabetologia | Ausgabe 12/2007

Einloggen, um Zugang zu erhalten

Excerpt

To the Editor: The Editor’s erudite commentary [1] on the accelerator hypothesis and its impact on the classification of diabetes [2] points to where the hypothesis may be vulnerable, offers the opportunity for adjustment and sets an intellectual standard by which the hypothesis will stand or fall. The hypothesis is based on the construct of tempo [3], and envisages a hierarchy of genotypes that respond to insulin resistance with corresponding rates of beta cell loss. Accordingly, a rise in insulin resistance across a population would predict a leftward shift, resulting in younger age at onset and an increase in incidence, both fundamental tenets of the hypothesis because they spell acceleration. …

Gale EAM (2007) To boldly go—or to go too boldly? The accelerator hypothesis revisited. Diabetologia 50:1571–1575PubMedCrossRef

Wilkin TJ (2007) Changing perspectives in diabetes: their impact on its classification. Diabetologia 50:1587–1592PubMedCrossRef

Wilkin TJ (2001) The accelerator hypothesis: weight gain as the missing link between type I and type ll diabetes. Diabetologia 44:914–922PubMedCrossRef

Wilkin TJ (2007) The accelerator hypothesis cannot be tested using the type 2 diabetes gene, TCF7L2. Diabetologia 50:1780PubMedCrossRef

Field SF, Howson JMM, Smyth DJ, Walker NM, Dunger DB, Todd JA (2007) Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects. Diabetologia 50:212–213PubMedCrossRef

Field SF, Howson JMM, Walker NM, Dunger DB, Todd JA (2007) Analysis of the obesity gene FTO in 14,803 type 1 diabetes cases and controls. Diabetologia DOI 10.1007/s00125-007-0767-0

Hawa MI, Bonfanti R, Valeri C, Delli Castelli M, Beyan H, Leslie RD (2005) No evidence for genetically determined alteration in insulin secretion or sensitivity predisposing to type 1 diabetes: a study of identical twins. Diabetes Care 28:1415–1418PubMedCrossRef

Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC (2004) Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 47:1661–1667PubMedCrossRef

Diabetes Prevention Trial–Type 1 Diabetes Study Group (2002) Effects of insulin on relatives of patients with type 1 diabetes. N Engl J Med 346:1658–1691CrossRef

10.

The European Nicotinamide Diabetes Intervention Trial (ENDIT) Group (2002) A randomised controlled trial of intervention before the onset of type 1 diabetes. Lancet 363:925–931

11.

Dabelea D, D’Agostino RB, Mayer-Davis EJ et al (2006) Testing the accelerator hypothesis: body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes. Diabetes Care 29:290–294PubMedCrossRef

12.

Wilkin TJ (2006) Testing the accelerator hypothesis: body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes: response to Dabelea et al. Diabetes Care 29:1462–1463 (author reply 1463–1464)PubMedCrossRef

13.

Knowler WC, Barrett-Connor E, Fowler SE et al.; Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403PubMedCrossRef

Titel: Comment on: Gale EAM (2007) To boldly go—or to go too boldly? The accelerator hypothesis revisited. Diabetologia 50:1571–1575—a reply to the editor
verfasst von: T. J. Wilkin
Publikationsdatum: 01.12.2007
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 12/2007
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-007-0829-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Comment on: Gale EAM (2007) To boldly go—or to go too boldly? The accelerator hypothesis revisited. Diabetologia 50:1571–1575—a reply to the editor

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2007

Increased physical activity is a cornerstone in the prevention of type 2 diabetes in high-risk individuals

The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients

Increased physical activity is a cornerstone in the prevention of type 2 diabetes in high-risk individuals. Reply to Laaksonen DE, Lindström J, Tuomilehto J, Uusitupa M [letter]

Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989

Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans

Renal carcinogenesis in models of diabetes in rats—metabolic changes are closely related to neoplastic development

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin